SAN DIEGO — Genesee Scientific, a prominent supplier of laboratory essentials for the life sciences industry, has appointed Jeff Jochims as Executive Chair of the Board. The move marks a strategic step for the company as it seeks to accelerate its growth and expand its presence across research and diagnostic markets.
Jochims, who joined Genesee’s Board of Directors in 2023, brings more than 25 years of leadership experience in healthcare and life sciences distribution. His career includes senior executive roles at Thermo Fisher Scientific and Owens & Minor, and he currently serves as CEO of I2Pure, a life sciences company focused on infection prevention technologies.
“Jeff’s deep industry expertise and strategic vision make him an exceptional fit for Genesee Scientific at this critical stage of our growth,” said Dan Monahan, CEO of Genesee Scientific. “His experience scaling operational excellence and commercial strategy will be key as we broaden our impact in the life sciences space.”
Genesee Scientific provides a wide range of products to support laboratories in both academic and clinical settings. The company is positioning itself for continued expansion amid growing demand for cost-effective, high-quality lab solutions.
Jochims said he is eager to help lead the next phase of the company’s evolution. “Genesee Scientific has a strong foundation and a clear value proposition,” he said. “With a passionate team committed to supporting scientists, I look forward to shaping its future and helping to drive continued success.”
His appointment underscores the company’s focus on scaling its operations and enhancing its role as a key supplier to the life sciences community.
